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Aims: Stress urinary incontinence (SUI) impacts many women. Treatment is primarily surgical.
Post-operative morbidity considerably a¡ects individuals and the health care system. Our objective
is to describe complications following surgery for SUI and how they a¡ect resource utilization.
Methods: Utilizing the Nationwide Inpatient Sample (a nationally representative dataset),
147,473 patients who underwent surgery for SUI from 1988 to 2000 were identi¢ed by ICD-9 codes.
Comorbid conditions/complications were extracted using ICD-9 codes, including complication
rates, length of stay (LOS), hospital charges, and discharge status. Results: Overall complication rate
was 13.0% (not equal to sum of complication sub-types, as each woman may have had¼ 1 complication),
with 2.8% bleeding, 1.4% surgical injury, 4.3% urinary/renal, 4.4% infectious, 0.1% wound, 1.1%
pulmonary insu⁄ciency, 0.5% myocardial infarction, 0.2% thromboembolic. The ‘‘gold standard’’
surgical technique for SUI, the pubovaginal sling, had the lowest morbidity at 12.5%. Mean LOS
increased with morbidity: from 2.9 to 4.1 to 6.1 days for those with 0, 1, and ¼2 complications
respectively (P < 0.001). Similarly, in£ation-adjusted hospital charges increased with morbidity:
from $7,918 to $9,828 to $15,181 for those with 0, 1, and ¼2 complications respectively (P < 0.001).
The percentage of patients requiring post-discharge subacute or home care increased with
morbidity: from 4.4% to 8.4% to 14.3% for those with 0, 1, and ¼2 complications (P < 0.001).
Conclusions: A substantial percentage of women experience complications following surgery for
SUI. Post-operative morbidity leads to dramatically increased resource utilization. Prospective stu-
dies are needed to identify pre-operative risk factors and intraoperative process measures to opti-
mize the quality of care. Neurourol. Urodynam. 24:659 ^665, 2005.  2005 Wiley-Liss, Inc.
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INTRODUCTION
Up to one-third of adult woman in theUnited States experi-
ence involuntary loss of urine at an estimated annual cost of
over $12.4 billion in 1995 [Hampel et al., 1997; Wilson et al.,
2001]. Stress urinary incontinence (SUI) is the most common
type of urinary incontinence in women under the age of 60,
and it accounts for approximately half of incontinence in all
women [Hannestad et al., 2000]. While pelvic £oor therapy,
behavior modi¢cation, biofeedback, and medical treatment
can lead to moderate improvement in SUI symptomatology,
a paucity of data exists with regard to long-term therapy and
outcomes. Surgical intervention remains the mainstay of ther-
apy for SUI, although the optimal procedure remains at the
discretion of the surgeon.
In the United States, the current healthcare climate is
typi¢ed by increasing public scrutiny of quality of care
delivered by its providers [Chassin andGalvin, 1998; Institute
of Medicine, 2001]. As a result, patients, payers, and policy
makers are seeking to identify reliable indicators in order to
assess quality of care. Within surgical disciplines, direct
evaluation of outcomes has been fundamental in assessing
quality of care; and, post-operative morbidity has been shown
to vary signi¢cantly among hospitals across the nation [Khuri
et al., 1998; Dimick et al., 2003]. Post-operative complications
can have a devastating e¡ect on the individual patient as well
as lead to substantial additional costs to the health care system.
Most information about surgery for SUI is from large single
institution series and focuses on post-operative urinary
retention and incontinence. Little data exists regarding mor-
bidity following surgical intervention for SUI [Glazener and
Cooper, 2001, 2004]. Thus, the aim of this study is to describe
the frequency and nature of complications following surgery
for SUI and how they a¡ect resource utilization using a
nationally representative dataset.
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The Nationwide Inpatient Sample (NIS) dataset is a 20%
strati¢ed sample of all hospital discharges in theUnited States.
It is maintained by the Agency for Health Care Research and
Quality (AHRQ) as part of the Healthcare Cost and Utiliza-
tion Project (HCUP) [Healthcare Cost and Utilization
Project (HCUP-6), 1997]. Data for this study were derived
from the NIS dataset for the years 1988 through 2000. The
NIS is a 20% strati¢ed, random sample of all hospital dis-
charges in theUnited States. All patients who were discharged
from NIS participating hospitals between 1988 and 2000
with a primary International Classi¢cation of Disease, Ninth
Revision, Clinical Modi¢cation (ICD-9-CM) procedure code
for a SUI surgery were included. In addition, an ICD-9-CM
diagnostic code for SUI was necessary for inclusion. All
numeric codes described herein refer to ICD-9-CMprocedure
and diagnostic codes. According to federal regulations, CFR
Title 45 Section 46.101 subparagraph (b)(4) explicitly states
that IRB approval is not needed for datasets that are publicly
available or that keep patient information anonymous [Code
of Federal Regulations, 2004]. Both requirements are met by
theNIS dataset.
Stress incontinence procedures in our analysis included
plication of the urethrovesical junction (59.3), suprapubic sling
(59.4), retropubic urethral suspensions (59.5), paraurethral
needle suspensions (59.6), levator muscle urethrovesical sus-
pension operations (59.71), other repair for SUI (59.7, 59.79,
58.49, 57.89), injection of implantable material into urethra
and/or bladder neck (59.72), implantation of arti¢cial urinary
sphincter (58.93), cystourethroplasty and repair of bladder
neck (57.85), and anterior repair or cystocele (70.5, 70.50,
70.51). Any cases that had a coincident procedure code for
hysterectomy (68.3, 68.4, 68.5, 68.9) were excluded so as to not
confound the complication rates for SUI procedures with
those of a more invasive procedure. The following ICD-9
diagnostic codes were employed to con¢rm that the pro-
cedure was performed for an SUI diagnosis rather than for
another indication (i.e., pelvic prolapse): SUI (625.6), in-
trinsic sphincter de¢ciency (599.82), unspeci¢ed incontinence
(788.3, 788.30, 788.39), urethral hypermobility/instability
(599.81, 599.83), and mixed urinary incontinence (788.33).
IndependentVariables
Patient demographic information including age, race,
gender, primary insurance type, and median income in
patients’ zip code, as well as type of admission and year of
treatment were abstracted. Secondary ICD-9-CM diagnostic
codes were abstracted to enumerate comorbid conditions ac-
cording to the Romano modi¢cation of the Charlson comor-
bidity index [Charlson et al., 1987; Romano et al., 1993].
Hospital factors including geographic region, teaching status,
bed size, and rural versus urban location were abstracted from
the dataset.
OutcomeVariables
The primary outcome variable was complication rate.
Complications were abstracted from the dataset using ICD-9
diagnostic codes in similar fashion to the Complications
Screening Program [Iezzoni et al., 1994]. Bleeding complica-
tions included post-procedure hemorrhage (998.1, 998.11,
998.12), acute blood loss anemia (285.1), and blood transfusion
(V582 and procedure codes 99.0^99.07). Surgical injury
complications included injury to pelvic organs (867.0^867.9),
accidental puncture or laceration during surgery (998.2), and
surgical repair of laceration to urinary tract (procedure codes
56.82, 57.81, 58.41). Urinary and renal complications were
urinary obstruction (599.6), urinary retention (788.2^788.29),
acute renal failure (584^585.9), and urinary complications not
otherwise speci¢ed (997.5). Infectious complications included
sepsis (038), urinary tract infection (595.9, 597.80^597.89,
599.0, 996.64), post-operative infection not otherwise speci¢ed
(998.5, 998.59), genital cellulitis (616.1, 616.10),Clostridium dif-
¢cile colitis (008.45), pyelonephritis (590.1, 590.10, 590.11,
590.2, 590.80, 590.9), and pneumonia (481^486, 507-507.8).
Wound complications included seroma (998.13), dehiscence
(998.3), post-operative wound infection (998.51). Pulmonary in-
su⁄ciency complications included pulmonary edema (518.4),
pulmonary insu⁄ciency following surgery (581.5), acute
respiratory failure (518.81, 518.82), and respiratory complica-
tions (997.3). Post-operative myocardial infarction included
410^ 410.91 and 997.1. Cerebrovascular complications includ-
ed 997.01 and 997.02. Thromboembolic complications includ-
ed thrombosis of deep lower extremity veins (451.1^ 451.2),
venous system thrombosis and embolism (453.8, 453.9), throm-
bophlebitis (451, 451.8, 451.81, 451.9), and pulmonary embolism
(415.1^ 415.19).
Other outcomes of interest were LOS, discharge status
(need for subacute or home healthcare services), in£ation-
adjusted hospital charges, and in-hospital mortality as
reported by the NIS dataset. Hospital charges were adjusted
to year 2000 levels using the consumer price index as reported
by the Bureau of Labor Statistics of the U.S. Department of
Labor [United States Department of Labor, 2003].
Statistical Analyses
Descriptive statistics for characteristics of all patients
undergoing surgical intervention for SUI was conducted.
Bivariate comparisons were performed using chi-square and
analysis of variance (ANOVA) where appropriate. Risk adjust-
ment consisted of demographic characteristics (age, gender,
and race), comorbidity score, hospital factors (teaching status,
bedsize, and region), time period, and type of procedure. A
multivariable regression model was developed in a back-
ward fashion to determine the association of morbidity with
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independent factors. All hypothesis testing was perform-
ed at a 5% signi¢cance level using statistical software
(Statistical Package for Social Sciences Version 11.0; SPSS,
Inc., Chicago, IL).
RESULTS
Using the NIS, 150,115 patients were identi¢ed as having a
primary surgical procedure for SUI from 1988 to 2000. This
number decreased to 147,473 when excluding patients who
had a concurrent hysterectomy. Patient demographic and
hospital data as well as their association with morbidity are
presented in Table I. Increasing age was associated with a
signi¢cant, stepwise increase in morbidity. Complication
rates were relatively steady among di¡ering racial groups with
the exception of Hispanics, who were noted to have a
markedly lower rate of adverse events (11.5%). Patients with
Medicare had signi¢cantly higher morbidity (16.2%) com-
pared to patients with other payers (11.3^12.0%). Patients with
increasing comorbidity also experienced a greater complica-
tion rate. However, the overall cohort was relatively healthy
with over 87% of women having a Charlson co-morbidity
score of 0. Morbidity varied by hospital region,with the lowest
complication rate in the West (11.5%) and the highest in the
South (14.1%).Table II classi¢es the complications by bleeding,
infectious, urinary/renal, surgical injury, pulmonary insuf-
¢ciency, myocardial infarction, thromboembolic, wound-
related, and cerebrovascular.
The frequency of each type of surgical procedure for SUI
and its associated complication rate is illustrated in Table III.
Pubovaginal slings and other repairs for SUI were noted to
have the lowest morbidity at 12.5 and 11.5% respectively.
Patients undergoing arti¢cial urinary sphincter placement
and injection of implantable material had the highest morbid-
ity at 30.9 and 20.0% respectively. Of the study sample,
7,031 patients (4.8%) underwent concomitant vaginal sus-
pension/¢xation and 1,448 of them (20.6%) experienced a
complication. Similarly, 35,683 patients (24.2%) had a con-
current rectocele repair, and of those, 5,505 (15.4%) had a
complication.
The in-hospital mortality rate for women undergoing
incontinence surgery from 1988 to 2000 was 0.03%. For those
who experienced one complication, the mortality rate rose to
0.1%. For those who experienced 2 or more complications, the
mortality rate reached 0.8%.The association ofmorbidity with
resource utilization is summarized in Table IV. The overall
mean LOS was 3.1 days. LOS increased with increasing
morbidity: from 2.9 days for those patients without complica-
tions to 4.1 days for those with one complication and 6.1 days
for those with two or more (P < 0.001). Mean in£ation-
adjusted hospital charges was $8,247. Similarly, hospital
charges increased with morbidity: from $7,918 for those with-
out complications to $9,828 for those with one complication to
$15,181 for those with two or more complications (p < 0.001).
The overall rate for patients requiring post-discharge care (in
TABLE I. Patient and Hospital Characteristics as Well
as Their Associated Morbidity for Surgical Procedures






<40 years 13,352 1,343 (10.1)
40^ 49 years 30,830 3,321 (10.8)
50^59 years 34,905 4,066 (11.6)
60^ 69 years 36,037 4,992 (13.9)
70 years 32,319 5,498 (17.0)
Race <0.001
White 87,983 12,094 (13.7)
Black 3,033 422 (13.9)
Hispanic 7,044 812 (11.5)
Asian 774 104 (13.4)
Other 1,354 181 (13.4)
Missing 47,285 5,616 (11.9)
InsuranceType <0.001
Medicare 50,440 8,154 (16.2)
Medicaid 8,239 956 (11.6)
Private/HMO 81,316 9,220 (11.3)




<$25,000 28,336 3,855 (14.4)
$25,000^$34,999 50,169 6,443 (13.7)
$35,000^$44,999 31,795 3,966 (13.5)
$45,000 24,366 3,120 (14.1)




CI ¼ 0 128,385 16,363 (12.7)
CI ¼ 1 16,599 2,437 (14.7)
CI  2 2,489 429 (17.2)
Hospital type 0.356
Rural 22,802 2,987 (13.1)
Urban, non-teaching 79,996 10,336 (12.9)
Urban, teaching 44,289 5,846 (13.2)
Hospital bed size 0.636
Small 18,100 2,349 (13.0)
Medium 47,876 6,297 (13.2)
Large 81,111 10,523(13.0)
Region <0.001
Northeast 24,088 3,208 (13.3)
Midwest 32,518 4,232 (13.0)
South 51,595 7,265 (14.1)




1988^1991 35,957 4,542 (12.6)
1992^1994 32,962 4,943 (15.0)
1995^1997 39,789 5,481 (13.8)
1998^2000 38,765 4,263 (11.0)
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the formof subacute facilities or home healthcare services) was
5.0%. The percentage of patients requiring post-discharge
care increased with morbidity: from 4.4% to 8.4% to 14.3% for
those with zero, one, and two complications respectively
(P < 0.001). TableVdescribes the signi¢cant factors associated
with morbidity following surgical procedures for SUI.
DISCUSSION
The evaluation and treatment of women with urinary
incontinence is gaining widespread attention in clinical urolo-
gic and urogynecologic practice as well as in national and
international research. Surgical interventions for SUI are
commonly performed and there are a variety of procedures
available. Information on outcomes following surgery for
SUI in women is mainly based on large case series however
there are currently a number of prospective, multi-institu-
tional trials ongoing. Population-based estimates of the rates
of surgical interventions for SUI in the United States have
been reported. Some have also reported complication rates
[Boyles et al., 2003; Waetjen et al., 2003], but limited data exists
relating the nature of the complications to resource utiliza-
tion. Our study provides population-based outcomes from a
nationally representative sample of several hundred hospitals
that perform surgery for women with SUI. By our review of
the contemporary literature, the current study is the ¢rst to
describe that increased morbidity following surgical interven-
tion for SUI leads to increased resource utilization.
It seems intuitive that post-operative complications would
lead to increased resource utilization; however, this has not
been quanti¢ed for women undergoing surgery for SUI. The
current study reports that complications do indeed have a
measurable e¡ect on healthcare consumption and can be
quanti¢ed in terms of increased LOS, increased charges and
post-discharge care. Mean LOS doubled and mean in£ation-
adjusted charges were almost twice that for women with more
than two complications compared with women who ex-
perienced no post-operative complications. Utilization of
post-discharge care (need for subacute or home healthcare
services) almost tripled when comparing the two groups.
Although most of the complications reported following SUI
surgery could be considered non-life threatening, they do
nevertheless lead to signi¢cantly increased utilization of
healthcare resources. What remains undetermined is how
these minor complications impact quality of life for patients
during their convalescence. Further study in this arena is
warranted.
Other studies have utilized administrative data to examine
complication rates for SUI procedures. Using the National
Hospital Discharge Survey (NHDS) from1979 to1997, Boyles
et al. reported a 6.5% overall complication rate. Women who
had more than one procedure performed (37%) were no more
likely to have a complication than the women who underwent
only one procedure. In contrast, the current study found that
patients undergoing paraurethral suspension or pubovaginal
sling procedures were more likely to experience complica-
tions when combined with another procedure versus alone.
Akin to the current study, Boyles et al. [2003] reported that
women with pre-operative comorbidities were more likely to
have a complication (10.4%) compared to those without (5.8%).
Using 1988 NHDS data,Waetjen et al. [2003] determined that
68% of surgeries for SUI were performed concomitantly with
a gynecologic procedure and approximately half of those were
TABLE II. Categorization of Complications Following




Bleeding complications 4,178 2.8
Infectious complications 6,481 4.4
Urinary/renal complications 6,292 4.3
Surgical injury 2,082 1.4
Pulmonary insu⁄ciency 1,555 1.1
Myocardial infarction 749 0.5
Thromboembolic complications




Cerebrovascular complications 46 0.03
All complications 19,229 13.0
aNot equal to sum of each complication, as each woman may have more than
one complication.
TABLE III. Type of Surgery for SUI and its Associated Morbidity Rate in the United States
From 1988 to 2000
Frequency of procedures (%) Frequency of complications (%)
Pubovaginal sling 13,082 (8.9) 1,633 (12.5)
Retropubic suspension 42,643 (28.9) 6,350 (14.9)
Paraurethral (needle) suspension 6,300 (4.3) 919 (14.6)
Collagen injection 878 (0.6) 176 (20.0)
Arti¢cial urinary sphincter placement 123 (0.1) 38 (30.9)
Bladder neck repaircystourethroplasty 680 (0.5) 91 (13.4)
Anterior repair (including UVJ plication) 46,864 (31.8) 6,576 (14.0)
Other repair for urinary stress incontinence 63,674 (43.2) 7,491 (11.8)
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hysterectomies. In their study, 18.3% of women had one or
more complicationsmore speci¢cally, 17.1% when SUI sur-
gery was performed alone and 18.9% when in combination
with another procedure. In order to gain a clearer assessment
of the complications associated with surgical intervention for
SUI, the current study excluded women with concomitant
hysterectomy because its more invasive nature might con-
found the results. When all women who underwent SUI sur-
gery are analyzed (including those who had a hysterectomy),
the overall complication rate was 16.0%. Pelvic organ prolapse
TABLE IV. Association of Morbidity and Resource Utilization as Defined by Length of
Stay (LOS), Inflation-Adjusted Hospital Charges, and Requirement for Post-Discharge
Care Following Surgery for SUI
Mean LOS (95% CI)
Mean in£ation-adjusted
hospital charges (95% CI)
Percent requiring
post-discharge care (95% CI)a
0 Complications 2.9 (2.9^3.0) $7,918 ($7,879^7,957) 4.4% (4.3^ 4.5%)
1Complication 4.1 (4.0^ 4.1) $9,828 ($9,730^$9,925) 8.4% (8.0^8.8%)
2 Complications 6.1 (5.9^ 6.4) $15,181 ($14,184^$16,178) 14.3% (12.9^15.8%)
aAny patient discharged to a subacute facility or with home healthcare services.
TABLE V. Multivariable Analysis of Morbidity: Significant Predictors of Complications
Following Surgery for SUI




40^ 49 years 1.07 (1.00^1.15)
50^59 years 1.16 (1.08^1.23)
60^69 years Age < 40 years 1.27 (1.19^1.36)
70 years 1.53 (1.41^1.65)
Insurance type
Medicaid Insurance 0.91 (0.84^ 0.99)
Private/HMO Insurance Medicare 0.83 (0.79^ 0.87)
Other 0.83 (0.77^ 0.90)
Median income for zip code
25,000^34,999 1.00 (0.96^1.05)
35,000^ 44,999 <$25,000 1.05 (0.99^1.10)
$45,000 1.15 (1.09^1.21)
Comorbidity score
Charlson index ¼ 1 Charlson Index ¼ 0 1.12 (1.07^1.17)
Charlson index  2 1.30 (1.17^1.45)
Hospital region
Northeast 1.03 (0.97^1.08)
South Midwest 1.09 (1.04^1.13)
West 0.85 (0.81^ 0.89)
Time period
1992^1994 1.20 (1.15^1.26)
1995^1997 1988^1991 1.04 (0.99^1.08)
1998^2000 0.74 (0.70^ 0.77)
Procedure
Arti¢cial sphincter 3.53 (2.40^5.20)
Collagen 1.74 (1.47^2.06)
Retropubic suspension 1.42 (1.36^1.48)
Retropubic suspension þ another procedure 1.42 (1.34^1.50)
Pubovaginal sling 1.07 (1.00^1.15)
Pubovaginal slingþ another procedure 1.22 (1.12^1.32)
Paraurethral suspension 0.99 (0.91^1.08)
Paraurethral suspension þ another procedure 1.33 (1.22^1.45)
Rectocele 1.28 (1.23^1.33)
Vaginal suspension/¢xation 1.56 (1.46^1.66)
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surgery performed as secondary procedures were included
in the current study; and, patients undergoing prolapse sur-
gery experienced signi¢cantly higher morbidity. Further
assessment of the morbidity and mortality of SUI procedures
performed alone and in conjunctionwith other surgical proce-
dures deserves further investigation.
Kinchen et al. [2004] described issues related to health care
utilization in 3,735 women who underwent surgery for SUI
during 1995^2000, based on data reported by Medstat’s
MarketScan Commercial Claims and Encounters (CC&E)
and the Medicare Supplemental and Coordination of Bene¢ts
(COB) databases. These contain inpatient, outpatient, and
outpatient drug claim data. A small number of cases were
complicated by: infection (1.4%), bleeding (0.3%), and injury
to the ureters or bladder (0.05%). Overall, 8.5% of women
experienced urinary retention following surgery, with the
greatest number of patients (12.8%) having undergone sling
surgery. Conversely, we found that pubovaginal sling sur-
geries had low morbidity (12.5%), whereas arti¢cial urinary
sphincter (AUS) surgery and collagen injection carried the
highest morbidity (30.9 and 20.0%, respectively). The high
morbidity associated with AUS is not unexpected, given that
AUS is typically indicated only for women with refractory or
extremely complex SUI. The high morbidity associated with
collagen injection may be related to the time period of
data gathering by the NIS. Collagen injection was approved
by the Food and Drug Administration in 1996, and the
morbidity at this early stage of clinical experience was likely
greater than that experienced in current practice. The high
complication rate seen following collagen injection may re-
£ect that only the most ill patients are admitted to the hospital
post-operatively.
Another interesting ¢nding from the current study is the
increased complication rate in patients with greater comorbid
disease as measured by the Charlson Index: from 12.7% to
14.7% to 17.2% for those patients with a Charlson score of 0, 1,
and¼2 respectively (P < 0.001).The complications most asso-
ciated with increased comorbidity were infectious con-
ditions, pulmonary insu⁄ciency, thromboembolic events,
and myocardial infarction. In contrast, procedure-speci¢c
complications such as bleeding, surgical injury, wound trou-
bles, urinary obstruction or retention did not vary with
comorbidity.
Several limitations exist in the current study.TheNIS is an
administrative database composed of 20% of United States’
hospital discharges. Analysis of NIS data is limited by that
which was collected. The NIS dataset does not include past
obstetrical or surgical history; functional status; American
Society of Anesthesiologists score; or other clinical or physio-
logic patient data. Disease-speci¢c information is lacking,
such as urodynamic testing, extent of pelvic organ prolapse,
history of conservative treatment or prior pelvic surgery.
Because the NIS is limited to only inpatient data, the 13% of
women found to have complications following SUI surgery
likely underestimates the true morbidity. The increased avail-
ability and use of minimally invasive techniques has generated
a movement toward ambulatory surgery for SUI. A recent
report from Boyles et al. [2004] describing data in theNational
Survey of Ambulatory Surgery found that outpatient proce-
dures for urinary incontinence are performed at one ¢fth
the frequency of inpatient procedures [Boyles et al., 2004].
Ambulatory surgery for incontinence continues to become
increasingly common and will need to be studied in more
detail in terms of healthcare utilization and quality of care.
The widespread availability and utilization of the many
recently approved minimally invasive surgical procedures for
SUI in women since the late 1990s is not re£ected in our
report. Although there are speci¢c codes for the numerous
and varied surgical procedures available for the treatment of
women with SUI, we recognize that there is variation in how
the procedures are performed, where they are performed, and
how they are coded. Di¡erences in frequency and rate of com-
plications may re£ect physician practice, choice of surgical
intervention, patient characteristics, and incontinence sever-
ity.This dataset also does not record any patient reported out-
comes relating to morbidity. In describing the nature of
complications following incontinence surgery in particular,
patient related outcomes are recognized as very important in
terms of not only e⁄cacy but also morbidity.
Surgical interventions for SUI are relatively safe procedures
with low morbidity and mortality for most women. However,
when complications do occur, they lead to increased utiliza-
tion of healthcare resources, whether in terms of increased
hospital charges, prolonged LOS, need for home healthcare
services, prescription medication, additional o⁄ce visits, or
further surgical procedures. The continued introduction and
re¢nement of minimally invasive therapies for SUI will ide-
ally lead to less morbidity and mortality with time. However,
the e¡ect of these techniques on healthcare utilization has yet
to be fully determined. Potentially, the rapid adoption of
recently introduced surgical therapies for SUI may lead to
decreased success rates and the need for more revision proce-
dures with time, negating the up-front bene¢t from a utiliza-
tion standpoint of some newer procedures that may or may
not lack long-term durability and treatment e⁄cacy.
As the population ages, the absolute number of surgical pro-
cedures performed for SUI is likely to increase, as is the rate of
surgical procedures. They will likely be increasingly per-
formed in the ambulatory setting and on women of older age.
By our review, a considerable percentage of women experi-
ence post-operative complications following SUI surgery. It
will be important to identify those women with comorbid risk
factors that can be addressed pre-operatively, thereby mini-
mizing avoidable over-utilization of healthcare resources and
maximizing quality of care. Furthermore, ongoing research to
de¢ne causative and relational factors to the development and
progression of SUI in women will be directly bene¢cial to
reducing the incidence of SUI. This will make an even greater
impact on healthcare utilization with regard to the care of
women with SUI in theUnited States.
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CONCLUSION
A substantial percentage of women experience com-
plications following surgical intervention for SUI. This post-
operative morbidity leads to dramatically increased resource
utilization as measured by hospital LOS, in£ation-adjusted
hospital charges, and use of post-discharge care. Prospective
study is needed to identify clinical risk factors and intraopera-
tive process measures that may be used to optimize the quality
of care. The identi¢cation of potentially modi¢able factors
associated with greater morbidity and therefore greater
resource utilization may provide opportunities for improve-
ment in the quality of care.
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